Open Access
Issue
MATEC Web Conf.
Volume 404, 2024
2024 2nd International Conference on Materials Engineering, New Energy and Chemistry (MENEC 2024)
Article Number 04002
Number of page(s) 11
Section Pharmaceuticals, Environmental Science, and Toxicology
DOI https://doi.org/10.1051/matecconf/202440404002
Published online 24 October 2024
  1. J. Leung, T. Santo, S. Colledge-Frisby, T. Mekonen, K. Thomson, L. Degenhardt, J. P. Connor, W. Hall, D. Stjepanović, Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies. Pain medicine (Malden, Mass.), 23(8), 1442-1456 (2022) [CrossRef] [Google Scholar]
  2. A. Ricarte, J.A.R. Dalton, J. Giraldo, Structural Assessment of Agonist Efficacy in the µ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns. Journal of Chemical Information and Modeling, 61(3), 1251-1274 (2021) [CrossRef] [Google Scholar]
  3. H.O.J. Collier, A.C. Roy, Hypothesis Inhibition of E prostaglandin-sensitive Adenyl Cyclase as the Mechanism of Morphine Analgesia. Prostaglandins, 7(5), 361-376 (1974) [CrossRef] [Google Scholar]
  4. Y. Wang, V. A. Ngo, X. Wang, Stereoselective recognition of morphine enantiomers by µ-opioid receptor. National science review, 11(3), nwae029 (2024) [CrossRef] [Google Scholar]
  5. K.K. Abney, M. Bubser, Y. Du, K.A. Kozek, T.M. Bridges, C.W. Lindsley, J.S. Daniels, R.D. Morrison, K. Wickman, C.R. Hopkins, C.K. Jones, C.D. Weaver, Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain Models. ACS Chemical Neuroscience, 10(3), 1294-1299 (2018) [Google Scholar]
  6. R. Gulaboski, M. N. Cordeiro, N. Milhazes, J. Garrido, F. Borges, M. Jorge, C. M. Pereira, I. Bogeski, A. H. Morales, B. Naumoski, A. F. Silva, Evaluation of the lipophilic properties of opioids, amphetamine-like drugs, and metabolites through electrochemical studies at the interface between two immiscible solutions. Analytical Biochemistry, 361(2), 236-243 (2007) [CrossRef] [Google Scholar]
  7. A.C. Moffat, D. Osselton, B. Widdop, E. G. C. Clarke, Clarke’s Analysis of Drugs and poisons. London: Pharmaceutical Press (2003) [Google Scholar]
  8. G. Coverley, A.C. Moffat, Clarke’s Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-mortem Material (1986) [Google Scholar]
  9. A. Avdeef, D.A. Barrett, P.N. Shaw, R.D. Knaggs, S.S. Davis, Octanol-, Chloroform-, and Propylene Glycol Dipelargonat-Water Partitioning of Morphine-6-glucuronide and Other Related Opiates. Journal of Medicinal Chemistry, 39(22), 4377-4381 (1996) [CrossRef] [Google Scholar]
  10. D.E. Selley, C.-C. Cao, T. Sexton, J.A. Schwegel, T.J. Martin, S.R. Childers, µ Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine 11Abbreviations: 6- MAM, 6-monoacetylmorphine; GTPyS, guanosine-5’-O-(Y-thio)-triphosphate; DAMGO, [d-Ala2, (N-Me)Phe4, Gly5(OH)]enkephalin; M-6-G, morphine-6-ßd- glucuronide; and hMOR-C6, C6 rat glioma cells expressing human µ opioid receptors. Biochemical Pharmacology, 62(4), 447-455 (2001) [CrossRef] [Google Scholar]
  11. L. Werner, A. Machara, D.R. Adams, D.P. Cox, T. Hudlicky, Synthesis of Buprenorphine from Oripavine via N-Demethylation of Oripavine Quaternary Salts. The Journal of Organic Chemistry, 76(11), 4628-4634 (2011) [CrossRef] [Google Scholar]
  12. Z. Ding, R.B. Raffa, Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. British Journal of Pharmacology, 157(5), 831-843 (2009) [CrossRef] [Google Scholar]
  13. L. Pang, Y. Hao, G. Mi, C. Wang, W. Luo, K. Rou, J. Li, Z. Wu, Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS (London, England), 21 Suppl 8, S103-S107 (2007) [CrossRef] [Google Scholar]
  14. ascendhealthcharlotte.com. (2023). The Road To Recovery: Navigating Opioid Addiction With Behavioral Therapy | Ascend Health PLLC. [online] Available at: https://ascendhealthcharlotte.com/behavioral-therapy-for-opioid-addiction/ [Accessed 11 Jul. 2024]. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.